LIQUISPEX(TM) LIQUID B2M CONTROL LEVEL 1 AND 2

System, Test, Beta-2-microglobulin Immunological

CLINICAL CONTROLS, INC.

The following data is part of a premarket notification filed by Clinical Controls, Inc. with the FDA for Liquispex(tm) Liquid B2m Control Level 1 And 2.

Pre-market Notification Details

Device IDK946048
510k NumberK946048
Device Name:LIQUISPEX(TM) LIQUID B2M CONTROL LEVEL 1 AND 2
ClassificationSystem, Test, Beta-2-microglobulin Immunological
Applicant CLINICAL CONTROLS, INC. 750 FARROLL RD. SUITE B Grover Beach,  CA  93433
ContactJames F Godfrey
CorrespondentJames F Godfrey
CLINICAL CONTROLS, INC. 750 FARROLL RD. SUITE B Grover Beach,  CA  93433
Product CodeJZG  
CFR Regulation Number866.5630 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1994-12-12
Decision Date1995-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.